AI-generated analysis. Always verify with the original filing.
On February 27, 2026, Joseph DosSantos, SVP, Finance and Acting Chief Financial Officer of Celularity Inc., left the Company for personal reasons. The Company appointed John Sprague as Acting Chief Financial Officer on the same date.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers . On February 2
Joseph DosSantos
Effective: 2026-02-27
personal reasons
John Sprague
Effective: 2026-02-27